Literature DB >> 18230370

Insensitivity of cerebral oxygen transport to oxygen affinity of hemoglobin-based oxygen carriers.

Raymond C Koehler1, Clara Fronticelli, Enrico Bucci.   

Abstract

The cerebrovascular effects of exchange transfusion of various cell-free hemoglobins that possess different oxygen affinities are reviewed. Reducing hematocrit by transfusion of a non-oxygen-carrying solution dilates pial arterioles on the brain surface and increases cerebral blood flow to maintain a constant bulk oxygen transport to the brain. In contrast, transfusion of hemoglobins with P50 of 4-34 Torr causes constriction of pial arterioles that offsets the decrease in blood viscosity to maintain cerebral blood flow and oxygen transport. The autoregulatory constriction is dependent on synthesis of 20-HETE from arachidonic acid. This oxygen-dependent reaction is apparently enhanced by facilitated oxygen diffusion from the red cell to the endothelium arising from increased plasma oxygen solubility in the presence of low or high-affinity hemoglobin. Exchange transfusion of recombinant hemoglobin polymers with P50 of 3 and 18 Torr reduces infarct volume from experimental stroke. Cell-free hemoglobins do not require a P50 as high as red blood cell hemoglobin to facilitate oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230370      PMCID: PMC2562895          DOI: 10.1016/j.bbapap.2008.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance.

Authors:  Xiaoping Liu; Alexandre Samouilov; Jack R Lancaster; Jay L Zweier
Journal:  J Biol Chem       Date:  2002-05-10       Impact factor: 5.157

2.  Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes.

Authors:  Mahendra Kavdia; Nikolaos M Tsoukias; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

3.  Erythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin.

Authors:  Nikolaos M Tsoukias; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

4.  Vascular response to infusions of a nonextravasating hemoglobin polymer.

Authors:  Barbara Matheson; Herman E Kwansa; Enrico Bucci; Annette Rebel; Raymond C Koehler
Journal:  J Appl Physiol (1985)       Date:  2002-10

5.  The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers.

Authors:  M R McCarthy; K D Vandegriff; R M Winslow
Journal:  Biophys Chem       Date:  2001-08-30       Impact factor: 2.352

6.  Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance.

Authors:  T C Page; W R Light; C B McKay; J D Hellums
Journal:  Microvasc Res       Date:  1998-01       Impact factor: 3.514

7.  Production of 20-HETE and its role in autoregulation of cerebral blood flow.

Authors:  D Gebremedhin; A R Lange; T F Lowry; M R Taheri; E K Birks; A G Hudetz; J Narayanan; J R Falck; H Okamoto; R J Roman; K Nithipatikom; W B Campbell; D R Harder
Journal:  Circ Res       Date:  2000-07-07       Impact factor: 17.367

8.  Theoretical analysis of effects of blood substitute affinity and cooperativity on organ oxygen transport.

Authors:  Mahendra Kavdia; Roland N Pittman; Aleksander S Popel
Journal:  J Appl Physiol (1985)       Date:  2002-09-06

9.  A compartmental model for oxygen transport in brain microcirculation in the presence of blood substitutes.

Authors:  Maithili Sharan; Aleksander S Popel
Journal:  J Theor Biol       Date:  2002-06-21       Impact factor: 2.691

10.  Calculations of oxygen transport by red blood cells and hemoglobin solutions in capillaries.

Authors:  Arjun Vadapalli; Daniel Goldman; Aleksander S Popel
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2002-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.